Figure 4From: Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressureChanges from baseline of inflammatory parameters after 6 months of treatment with candesartan (*P<0.05). HMW-ADN, high molecular weight adiponectin; PAI-1, plasminogen activator inhibitor-1; VCAM-1, vascular cell adhesion molecule-1; U-8-OHdG, urinary 8-hydroxydeoxyguanosine.Back to article page